PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $263,000 | -12.3% | 92,237 | -11.3% | 0.00% | 0.0% |
Q1 2022 | $300,000 | -5.4% | 104,027 | +0.0% | 0.00% | 0.0% |
Q4 2021 | $317,000 | +23.8% | 104,010 | +184.7% | 0.00% | 0.0% |
Q3 2021 | $256,000 | -22.0% | 36,537 | +2.4% | 0.00% | 0.0% |
Q2 2021 | $328,000 | +16.7% | 35,666 | +23.5% | 0.00% | 0.0% |
Q1 2021 | $281,000 | +8.5% | 28,874 | +14.3% | 0.00% | 0.0% |
Q4 2020 | $259,000 | +23.9% | 25,259 | +21.9% | 0.00% | – |
Q3 2020 | $209,000 | +6.1% | 20,721 | +9.7% | 0.00% | – |
Q2 2020 | $197,000 | +48.1% | 18,881 | +19.7% | 0.00% | – |
Q1 2020 | $133,000 | -3.6% | 15,770 | 0.0% | 0.00% | – |
Q4 2019 | $138,000 | -0.7% | 15,770 | +22.2% | 0.00% | – |
Q3 2019 | $139,000 | -15.2% | 12,908 | 0.0% | 0.00% | – |
Q2 2019 | $164,000 | -98.1% | 12,908 | -94.3% | 0.00% | -100.0% |
Q1 2019 | $8,737,000 | -41.8% | 225,231 | -69.5% | 0.02% | -45.9% |
Q4 2018 | $15,014,000 | -21.0% | 737,783 | +77.9% | 0.04% | -5.1% |
Q3 2018 | $19,012,000 | +38.8% | 414,661 | +79.1% | 0.04% | +34.5% |
Q2 2018 | $13,693,000 | -45.3% | 231,495 | -37.1% | 0.03% | -45.3% |
Q1 2018 | $25,027,000 | +0.1% | 367,781 | +45.4% | 0.05% | +1.9% |
Q4 2017 | $25,009,000 | -30.5% | 253,007 | -15.8% | 0.05% | -32.5% |
Q3 2017 | $35,976,000 | +2974.9% | 300,424 | +2143.3% | 0.08% | +2466.7% |
Q2 2017 | $1,170,000 | +195.5% | 13,392 | +25.9% | 0.00% | +200.0% |
Q1 2017 | $396,000 | +21.5% | 10,633 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $326,000 | -54.3% | 10,633 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $713,000 | +124.9% | 10,633 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $317,000 | -1.9% | 10,633 | -3.2% | 0.00% | 0.0% |
Q1 2016 | $323,000 | -62.8% | 10,981 | -0.9% | 0.00% | -50.0% |
Q4 2015 | $869,000 | +0.2% | 11,078 | -3.7% | 0.00% | 0.0% |
Q3 2015 | $867,000 | -36.0% | 11,506 | -0.8% | 0.00% | -33.3% |
Q2 2015 | $1,354,000 | -91.8% | 11,595 | -83.4% | 0.00% | -91.9% |
Q1 2015 | $16,540,000 | +40.7% | 70,051 | +12.8% | 0.04% | +42.3% |
Q4 2014 | $11,754,000 | +0.5% | 62,100 | +26.7% | 0.03% | -3.7% |
Q3 2014 | $11,695,000 | +1119.5% | 49,019 | +237.3% | 0.03% | +1250.0% |
Q2 2014 | $959,000 | -39.0% | 14,532 | -3.8% | 0.00% | -50.0% |
Q1 2014 | $1,573,000 | +0.6% | 15,108 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $1,564,000 | +114.2% | 15,108 | +11.0% | 0.00% | +100.0% |
Q3 2013 | $730,000 | +20.9% | 13,608 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $604,000 | – | 13,608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |